Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
10/19/2009
Trade Name:
Fluarix
Generic or Proper Name (*):
Influenza Virus Vaccine*
Indications Studied:
Active immunization for the prevention of influenza disease caused by virus types A and B contained in the vaccine
Therapeutic Category:
Preventive Vaccine
Ages Studied:
6 months - <18 years
Study #:
1
Study Type:
Safety/Immunogenicity
Study Design:
Single-Blind/Non-inferiority to competitor
No Countries:
1
BPCA(B), PREA(P):
P
-
-